Intellia Therapeutics, Inc. - COM (NTLA)

Historical Portfolio Holders from Q1 2016 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
90.1M
Holdings value Q2 2024
$2.02B
Value change Q2 2024
-$19.3M
Grand Portfolio weight change Q2 2024
0%
Number of holders
283
Number of buys Q2 2024
153
Number of sells Q2 2024
-122
Average buys Q2 2024 %
+0.001%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 58.5K $1.2M +$498K $20.55 5
2024 Q2 90.1M $2.02B -$19.3M $22.38 286
2024 Q1 90.3M $2.48B +$140M $27.51 277
2023 Q4 85.2M $2.6B +$177M $30.49 289
2023 Q3 79.3M $2.51B +$26.6M $31.62 276
2023 Q2 78.2M $3.19B -$9.36M $40.78 286
2023 Q1 78.7M $2.93B +$26.8M $37.27 287
2022 Q4 78M $2.72B +$325M $34.89 291
2022 Q3 68M $3.8B -$9.34M $55.96 308
2022 Q2 67.6M $3.44B +$98.1M $51.76 284
2022 Q1 65.2M $4.72B -$28.7M $72.67 343
2021 Q4 64.2M $7.59B +$201M $118.24 361
2021 Q3 62.2M $8.34B +$38.2M $134.15 352
2021 Q2 61.9M $10B +$39.1M $161.91 334
2021 Q1 63M $5.05B +$269M $80.25 256
2020 Q4 61.8M $3.36B +$187M $54.40 242
2020 Q3 56.5M $1.13B +$49.6M $19.88 161
2020 Q2 53.9M $1.13B +$161M $21.02 159
2020 Q1 46.4M $568M +$9.02M $12.23 133
2019 Q4 45.6M $669M +$24.4M $14.67 137
2019 Q3 44.1M $589M +$69.2M $13.35 132
2019 Q2 38.8M $635M +$86.6M $16.37 143
2019 Q1 33.5M $570M +$44.7M $17.08 144
2018 Q4 31.5M $430M +$12.1M $13.65 135
2018 Q3 29.1M $833M +$9.98M $28.62 150
2018 Q2 28.8M $787M +$72.9M $27.36 152
2018 Q1 26.3M $554M +$48.1M $21.09 127
2017 Q4 24.2M $465M +$126M $19.22 110
2017 Q3 17.7M $439M +$20.5M $24.85 83
2017 Q2 16.8M $269M +$2.72M $16.00 82
2017 Q1 16.7M $236M -$10.7M $14.09 75
2016 Q4 18.4M $241M -$6.14M $13.11 66
2016 Q3 14.3M $243M +$998K $17.02 64
2016 Q2 14.1M $300M +$298M $21.35 61
2016 Q1 215 $4K $0 $18.60 1